Neuroscience Antibodies & Assays Market by Product (Reagent (Media, Sera, Stain, Enzymes, Probe), Instruments), Technology (Immunoassay (Elisa), Molecular Diagnostics), Application (IVD) & End User (Research Institute, Hospital) - Global Forecast to 2023

神経科学用抗体&アッセイの世界市場予測(~2023年)

◆タイトル:Neuroscience Antibodies & Assays Market by Product (Reagent (Media, Sera, Stain, Enzymes, Probe), Instruments), Technology (Immunoassay (Elisa), Molecular Diagnostics), Application (IVD) & End User (Research Institute, Hospital) - Global Forecast to 2023
◆商品コード:BT6283
◆調査・発行会社:MarketsandMarkets
◆発行日:2018年5月16日
◆ページ数:158
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:バイオ技術
◆販売価格オプション(消費税別)
Single User(1名利用)USD5,650 ⇒換算¥638,450見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥751,450見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥920,950見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

MarketsandMarketsが発行した当調査レポートでは、神経科学用抗体&アッセイの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品(試薬、装置)別分析、技術別分析、用途別分析、需要先別分析、神経科学用抗体&アッセイの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

The global neuroscience antibodies and assays market is expected to reach USD 4.18 Billion by 2023 from USD 2.57 Billion in 2018, at a CAGR of 10.2%. Growth in this market is driven by the rising incidence of neurological diseases, increasing investments in neuroscience research, and growth in the pharmaceutical and biotechnology industries.
This report segments the neuroscience antibodies and assays market into product, technology, application, end user, and region. Based on product, the neuroscience antibodies and assays market is segmented into equipment and consumables. The consumables segment accounted for the largest market share in 2017 and is expected to register the highest CAGR during the forecast period. The consistent usage of consumables and their frequent purchases, and rising government initiatives in the genomics and proteomics research sector are the major factors supporting the growth of this segment.

Based on technology, the neuroscience antibodies and assays market is segmented into immunoassays/immunochemistry, molecular diagnostics, clinical chemistry, and other technologies. The immunoassays/immunochemistry segment is expected to register the highest CAGR during the forecast period. The high growth of this segment is attributed to the development of novel antibodies and assays for immunoassay techniques, technological developments in immunoassays, and rising government initiatives in the genomics and proteomics research sector.

Based on application, the neuroscience antibodies and assays market is segmented into research, drug discovery and development, and in vitro diagnostics. The in vitro diagnostics applications segment is expected to register the highest CAGR during the forecast period. The high growth of this segment is attributed to the increasing incidence and prevalence of neurological diseases across the globe, especially in developing countries.

Based on end user, the neuroscience antibodies and assays market is segmented into pharmaceutical and biotechnology companies, academic and research institutes, and hospitals and diagnostic centers. The pharmaceutical and biotechnology companies segment is expected to account for the largest share of the neuroscience antibodies and assays market in 2018. The large share of this segment can be attributed to the high uptake of neuroscience antibodies in the drug discovery and development process and rising government initiatives in the genomics and proteomics research sectors.

Neuroscience Antibodies & Assays Market

In 2017, North America accounted for the largest market share followed by Europe and Asia. The increasing investments for the development of structure-based drug designs, growing research in the field of genomics and proteomics, rising demand for high-quality research tools for data reproducibility, and the focus of stakeholders on research projects involving proteins, associated biomolecules, and genes are the key factors driving the growth of the neuroscience antibodies and assays market in North America. However, the market in Asia is expected to register the highest CAGR during the forecast period. The high growth in the Asian market is attributed to factors such as growing research on proteomics and genomics, favorable funding scenario, and rising incidence of neurological diseases in the Asian region.

The neuroscience antibodies and assays market is highly competitive with the presence of several small and big players. Prominent players in the market include Thermo Fisher Scientific (US), Abcam (UK), Bio-Rad (US), and Merck KGaA (Germany) were the leading players in the neuroscience antibodies and assays market. Other major players include BioLegend (US), Cell Signaling Technology (US), F. Hoffmann-La Roche (Switzerland), GenScript (China), Rockland Immunochemicals (US), Santa Cruz Biotechnology (US), Siemens (Germany), and Tecan (Switzerland).

【レポートの目次】

1 Introduction (Page No. – 16)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 20)
2.1 Secondary Data
2.1.1 Secondary Source
2.2 Primary Data
2.2.1 Key Data From Primary Sources
2.3 Market Size Estimation
2.4 Market Breakdown and Data Triangulation
2.5 Assumptions for the Study

3 Executive Summary (Page No. – 28)

4 Premium Insights (Page No. – 32)
4.1 Neuroscience Antibodies and Assays: Market Overview
4.2 Neuroscience Antibodies and Assays Market, By Product (2018 vs 2023)
4.3 Europe: Neuroscience Antibodies and Assays Market, By Technology (2018)
4.4 Neuroscience Antibodies and Assays Market, By End User (2018–2023)
4.5 Neuroscience Antibodies and Assays Market: Geographic Growth Opportunities

5 Market Overview (Page No. – 37)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rising Incidence of Neurological Diseases
5.2.1.2 Increasing Investments in Neuroscience Research
5.2.1.3 Growth in the Pharmaceutical and Biotechnology Industries
5.2.2 Restraints
5.2.2.1 Quality and Cost Concerns Over the Production of Antibodies
5.2.3 Opportunities
5.2.3.1 Increasing Demand for Personalized Medicine
5.2.3.2 Emerging Markets to Offer Significant Growth Opportunities
5.2.3.3 Growing Focus on Biomarker Discovery

6 Neuroscience Antibodies and Assays Market, By Product (Page No. – 42)
6.1 Introduction
6.2 Consumables
6.2.1 Reagents
6.2.1.1 Media and Sera
6.2.1.2 Stains and Dyes
6.2.1.3 Fixatives
6.2.1.4 Buffers
6.2.1.5 Solvents
6.2.1.6 Enzymes, Proteins, and Peptides
6.2.1.7 Probes
6.2.1.8 Other Reagents
6.2.2 Antibodies
6.2.2.1 Primary Antibodies
6.2.2.2 Secondary Antibodies
6.2.3 Assay Kits
6.3 Instruments
6.3.1 Immunoassay Analyzers
6.3.2 Microplate Readers
6.3.3 Other Instruments

7 Neuroscience Antibodies and Assays Market, By Technology (Page No. – 60)
7.1 Introduction
7.2 Immunoassays/Immunochemistry
7.2.1 Enzyme-Linked Immunosorbent Assay (Elisa)
7.2.2 Western Blotting
7.2.3 Other Immunoassay Technologies
7.3 Molecular Diagnostics
7.4 Clinical Chemistry
7.5 Other Technologies

8 Neuroscience Antibodies and Assays Market, By Application (Page No. – 68)
8.1 Introduction
8.2 Drug Discovery & Development
8.3 Research
8.4 in Vitro Diagnostics

9 Neuroscience Antibodies and Assays Market, By End User (Page No. – 73)
9.1 Introduction
9.2 Pharmaceutical & Biotechnology Companies
9.3 Academic & Research Institutes
9.4 Hospitals & Diagnostics Centers

10 Neuroscience Antibodies and Assays Market, By Region (Page No. – 78)
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Rest of Europe (RoE)
10.4 Asia
10.5 Rest of the World (RoW)

11 Competitive Landscape (Page No. – 113)
11.1 Overview
11.2 Market Share Analysis, 2017
11.3 Competitive Scenario
11.3.1 Agreements, Partnerships, and Collaborations (2015–2018)
11.3.2 Expansions (2015–2018)
11.3.3 Product Launches (2015–2018)
11.3.4 Acquisitions (2015–2018)

12 Company Profiles (Page No. – 120)
(Business Overview, Products Offered, Recent Developments, MnM View)*
12.1 Thermo Fisher Scientific
12.2 Abcam
12.3 Bio-Rad
12.4 Merck KGaA
12.5 Cell Signaling Technology
12.6 Genscript
12.7 Rockland Immunochemicals
12.8 BioLegend
12.9 Santa Cruz Biotechnology
12.10 Tecan
12.11 F. Hoffmann-La Roche
12.12 Siemens

*Business Overview, Products Offered, Recent Developments, MnM View Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. – 148)
13.1 Insights Form Industry Experts
13.2 Discussion Guide
13.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.4 Introducing RT: Real-Time Market Intelligence
13.5 Available Customizations
13.6 Related Reports
13.7 Author Details

List of Tables (103 Tables)

Table 1 Neuroscience Antibodies and Assays Market, By Product, 2016–2023 (USD Million)
Table 2 Neuroscience Antibodies and Assays Market for Consumables, By Type, 2016–2023 (USD Million)
Table 3 Neuroscience Antibodies and Assays Market for Consumables, By Region, 2016–2023 (USD Million)
Table 4 Reagents Market, By Type, 2016–2023 (USD Million)
Table 5 Reagents Market, By Region, 2016–2023 (USD Million)
Table 6 Media & Sera Market, By Region, 2016–2023 (USD Million)
Table 7 Stains and Dyes Market, By Region, 2016–2023 (USD Million)
Table 8 Fixatives Market, By Region, 2016–2023 (USD Million)
Table 9 Buffers Market, By Region, 2016–2023 (USD Million)
Table 10 Solvents Market, By Region, 2016–2023 (USD Million)
Table 11 Enzymes, Proteins, and Peptides Market, By Region, 2016–2023 (USD Million)
Table 12 Probes Market, By Region, 2016–2023 (USD Million)
Table 13 Other Reagents Market, By Region, 2016–2023 (USD Million)
Table 14 Antibodies Market, By Type, 2016–2023 (USD Million)
Table 15 Antibodies Market, By Region, 2016–2023 (USD Million)
Table 16 Primary Antibodies Market, By Region, 2016–2023 (USD Million)
Table 17 Secondary Antibodies Market, By Region, 2016–2023 (USD Million)
Table 18 Assay Kits Market, By Region, 2016–2023 (USD Million)
Table 19 Neuroscience Antibodies and Assays Market for Instruments, By Type, 2016–2023 (USD Million)
Table 20 Neuroscience Antibodies and Assays Market for Instruments, By Region, 2016–2023 (USD Million)
Table 21 Immunoassay Analyzers Market, By Region, 2016–2023 (USD Million)
Table 22 Microplate Readers Market, By Region, 2016–2023 (USD Million)
Table 23 Other Instruments Market, By Region, 2016–2023 (USD Million)
Table 24 Neuroscience Antibodies and Assays Market, By Technology, 2016–2023 (USD Million)
Table 25 Immunoassays/Immunochemistry Market, By Type, 2016–2023 (USD Million)
Table 26 Immunoassays/Immunochemistry Market, By Region, 2016–2023 (USD Million)
Table 27 Elisa Market, By Region, 2016–2023 (USD Million)
Table 28 Western Blotting Market, By Region, 2016–2023 (USD Million)
Table 29 Other Immunoassay Technologies Market, By Region, 2016–2023 (USD Million)
Table 30 Molecular Diagnostics Market, By Region, 2016–2023 (USD Million)
Table 31 Clinical Chemistry Market, By Region, 2016–2023 (USD Million)
Table 32 Other Technologies Market, By Region, 2016–2023 (USD Million)
Table 33 Neuroscience Antibodies and Assays Market, By Application, 2016–2023 (USD Million)
Table 34 Neuroscience Antibodies and Assays Market for Drug Discovery and Development, By Region, 2016–2023 (USD Million)
Table 35 Neuroscience Antibodies and Assays Market for Research Applications, By Region, 2016–2023 (USD Million)
Table 36 Neuroscience Antibodies and Assays Market for in Vitro Diagnostics, By Region, 2016–2023 (USD Million)
Table 37 Neuroscience Antibodies and Assays Market, By End User, 2016–2023 (USD Million)
Table 38 Neuroscience Antibodies and Assays Market for Pharmaceutical & Biotechnology Companies, By Region, 2016–2023 (USD Million)
Table 39 Neuroscience Antibodies and Assays Market for Academic & Research Institutes, By Region, 2016–2023 (USD Million)
Table 40 Neuroscience Antibodies and Assays Market for Hospitals & Diagnostic Centers, By Region, 2016–2023 (USD Million)
Table 41 Neuroscience Antibodies and Assays Market, By Region, 2016–2023 (USD Million)
Table 42 North America: Neuroscience Antibodies and Assays Market, By Country, 2016–2023 (USD Million)
Table 43 North America: Neuroscience Antibodies and Assays Market, By Product, 2016–2023 (USD Million)
Table 44 North America: Neuroscience Antibodies and Assays Market for Consumables, By Type, 2016–2023 (USD Million)
Table 45 North America: Reagents Market, By Type, 2016–2023 (USD Million)
Table 46 North America: Antibodies Market, By Type, 2016–2023 (USD Million)
Table 47 North America: Neuroscience Antibodies and Assays Market for Instruments, By Type, 2016–2023 (USD Million)
Table 48 North America: Neuroscience Antibodies and Assays Market, By Technology, 2016–2023 (USD Million)
Table 49 North America: Immunoassays/Immunochemistry Market, By Type, 2016–2023 (USD Million)
Table 50 North America: Neuroscience Antibodies and Assays Market, By Application, 2016–2023 (USD Million)
Table 51 North America: Neuroscience Antibodies and Assays Market, By End User, 2016–2023 (USD Million)
Table 52 US: Neuroscience Antibodies and Assays Market, By Product, 2016–2023 (USD Million)
Table 53 US: Neuroscience Antibodies and Assays Market, By Technology, 2016–2023 (USD Million)
Table 54 US: Neuroscience Antibodies and Assays Market, By Application, 2016–2023 (USD Million)
Table 55 US: Neuroscience Antibodies and Assays Market, By End User, 2016–2023 (USD Million)
Table 56 Canada: Neuroscience Antibodies and Assays Market, By Product, 2016–2023 (USD Million)
Table 57 Canada: Neuroscience Antibodies and Assays Market, By Technology, 2016–2023 (USD Million)
Table 58 Canada: Neuroscience Antibodies and Assays Market, By Application, 2016–2023 (USD Million)
Table 59 Canada: Neuroscience Antibodies and Assays Market, By End User, 2016–2023 (USD Million)
Table 60 Europe: Neuroscience Antibodies and Assays Market, By Country, 2016–2023 (USD Million)
Table 61 Europe: Neuroscience Antibodies and Assays Market, By Product, 2016–2023 (USD Million)
Table 62 Europe: Neuroscience Antibodies and Assays Market for Consumables, By Type, 2016–2023 (USD Million)
Table 63 Europe: Reagents Market, By Type, 2016–2023 (USD Million)
Table 64 Europe: Antibodies Market, By Type, 2016–2023 (USD Million)
Table 65 Europe: Neuroscience Antibodies and Assays Market for Instruments, By Type, 2016–2023 (USD Million)
Table 66 Europe: Neuroscience Antibodies and Assays Market, By Technology, 2016–2023 (USD Million)
Table 67 Europe: Immunoassays/Immunochemistry Market, By Type, 2016–2023 (USD Million)
Table 68 Europe: Neuroscience Antibodies and Assays Market, By Application, 2016–2023 (USD Million)
Table 69 Europe: Neuroscience Antibodies and Assays Market, By End User, 2016–2023 (USD Million)
Table 70 Germany: Neuroscience Antibodies and Assays Market, By Product, 2016–2023 (USD Million)
Table 71 Germany: Neuroscience Antibodies and Assays Market, By Technology, 2016–2023 (USD Million)
Table 72 Germany: Neuroscience Antibodies and Assays Market, By Application, 2016–2023 (USD Million)
Table 73 Germany: Neuroscience Antibodies and Assays Market, By End User, 2016–2023 (USD Million)
Table 74 UK: Neuroscience Antibodies and Assays Market, By Product, 2016–2023 (USD Million)
Table 75 UK: Neuroscience Antibodies and Assays Market, By Technology, 2016–2023 (USD Million)
Table 76 UK: Neuroscience Antibodies and Assays Market, By Application, 2016–2023 (USD Million)
Table 77 UK: Neuroscience Antibodies and Assays Market, By End User, 2016–2023 (USD Million)
Table 78 France: Neuroscience Antibodies and Assays Market, By Product, 2016–2023 (USD Million)
Table 79 France: Neuroscience Antibodies and Assays Market, By Technology, 2016–2023 (USD Million)
Table 80 France: Neuroscience Antibodies and Assays Market, By Application, 2016–2023 (USD Million)
Table 81 France: Neuroscience Antibodies and Assays Market, By End User, 2016–2023 (USD Million)
Table 82 RoE: Neuroscience Antibodies and Assays Market, By Product, 2016–2023 (USD Million)
Table 83 RoE: Neuroscience Antibodies and Assays Market, By Technology, 2016–2023 (USD Million)
Table 84 RoE: Neuroscience Antibodies and Assays Market, By Application, 2016–2023 (USD Million)
Table 85 RoE: Neuroscience Antibodies and Assays Market, By End User, 2016–2023 (USD Million)
Table 86 Asia: Neuroscience Antibodies and Assays Market, By Product, 2016–2023 (USD Million)
Table 87 Asia: Neuroscience Antibodies and Assays Market for Consumables, By Type, 2016–2023 (USD Million)
Table 88 Asia: Reagents Market, By Type, 2016–2023 (USD Million)
Table 89 Asia: Antibodies Market, By Type, 2016–2023 (USD Million)
Table 90 Asia: Neuroscience Antibodies and Assays Market for Instruments, By Type, 2016–2023 (USD Million)
Table 91 Asia: Neuroscience Antibodies and Assays Market, By Technology, 2016–2023 (USD Million)
Table 92 Asia: Immunoassays/Immunochemistry Market, By Type, 2016–2023 (USD Million)
Table 93 Asia: Neuroscience Antibodies and Assays Market, By Application, 2016–2023 (USD Million)
Table 94 Asia: Neuroscience Antibodies and Assays Market, By End User, 2016–2023 (USD Million)
Table 95 RoW: Neuroscience Antibodies and Assays Market, By Product, 2016–2023 (USD Million)
Table 96 RoW: Neuroscience Antibodies and Assays Market for Consumables, By Type, 2016–2023 (USD Million)
Table 97 RoW: Reagents Market, By Type, 2016–2023 (USD Million)
Table 98 RoW: Antibodies Market, By Type, 2016–2023 (USD Million)
Table 99 RoW: Neuroscience Antibodies and Assays Market for Instruments, By Type, 2016–2023 (USD Million)
Table 100 RoW: Neuroscience Antibodies and Assays Market, By Technology, 2016–2023 (USD Million)
Table 101 RoW: Immunoassays/Immunochemistry Market, By Type, 2016–2023 (USD Million)
Table 102 RoW: Neuroscience Antibodies and Assays Market, By Application, 2016–2023 (USD Million)
Table 103 RoW: Neuroscience Antibodies and Assays Market, By End User, 2016–2023 (USD Million)

List of Figures (35 Figures)

Figure 1 Research Design
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Market Size Estimation: Bottom-Up Approach
Figure 4 Market Size Estimation: Top-Down Approach
Figure 5 Data Triangulation Methodology
Figure 6 Neuroscience Antibodies and Assays Market, By Product, 2018 vs 2023 (USD Billion)
Figure 7 Neuroscience Antibodies and Assays Market, By Technology, 2018 vs 2023 (USD Billion)
Figure 8 Neuroscience Antibodies and Assays Market, By Application, 2018 vs 2023 (USD Billion)
Figure 9 Neuroscience Antibodies and Assays Market, By End User, 2018 vs 2023 (USD Billion)
Figure 10 Geographical Snapshot of the Neuroscience Antibodies and Assays Market
Figure 11 Increasing Prevalence of Neurological Diseases–Key Factor Propelling the Market for Neuroscience Antibodies and Assays
Figure 12 Consumables Will Continue to Dominate the Neuroscience Antibodies and Assays Market in 2023
Figure 13 Immunoassays/Immunochemistry to Command the Largest Share of the European Neuroscience Antibodies and Assays Market in 2018
Figure 14 Hospitals and Diagnostics Centers to Register the Highest Growth Rate Between 2018 & 2023
Figure 15 Asia to Witness the Highest Growth in the Neuroscience Antibodies and Assays Market During the Forecast Period (2018–2023)
Figure 16 Neuroscience Antibodies and Assays Market: Drivers, Restraints, and Opportunities
Figure 17 Neuroscience Antibodies and Assays Market, By Product, 2018 vs 2023 (USD Million)
Figure 18 Neuroscience Antibodies and Assays Market, By Technology, 2018 vs 2023 (USD Million)
Figure 19 Neuroscience Antibodies and Assays Market, By Application, 2018 vs 2023 (USD Million)
Figure 20 Neuroscience Antibodies and Assays Market, By End User, 2018 vs 2023 (USD Million)
Figure 21 North America: Neuroscience Antibodies and Assays Market Snapshot
Figure 22 Europe: Neuroscience Antibodies and Assays Market Snapshot
Figure 23 Asia: Neuroscience Antibodies and Assays Market Snapshot
Figure 24 RoW: Neuroscience Antibodies and Assays Market Snapshot
Figure 25 Key Developments in the Neuroscience Antibodies and Assays Market Between 2015 to 2018
Figure 26 Market Evolution Framework
Figure 27 Neuroscience Antibodies and Assays Market Share Analysis, By Key Player, 2017
Figure 28 Thermo Fisher Scientific: Company Snapshot
Figure 29 Abcam: Company Snapshot
Figure 30 Bio-Rad: Company Snapshot
Figure 31 Merck KGaA: Company Snapshot
Figure 32 Genscript: Company Snapshot
Figure 33 Tecan: Company Snapshot
Figure 34 F. Hoffmann-La Roche: Company Snapshot
Figure 35 Siemens: Company Snapshot



【レポートのキーワード】

神経科学用抗体、神経科学用アッセイ

★調査レポート[神経科学用抗体&アッセイの世界市場予測(~2023年)] ( Neuroscience Antibodies & Assays Market by Product (Reagent (Media, Sera, Stain, Enzymes, Probe), Instruments), Technology (Immunoassay (Elisa), Molecular Diagnostics), Application (IVD) & End User (Research Institute, Hospital) - Global Forecast to 2023 / BT6283) 販売に関する免責事項
[神経科学用抗体&アッセイの世界市場予測(~2023年)] ( Neuroscience Antibodies & Assays Market by Product (Reagent (Media, Sera, Stain, Enzymes, Probe), Instruments), Technology (Immunoassay (Elisa), Molecular Diagnostics), Application (IVD) & End User (Research Institute, Hospital) - Global Forecast to 2023 / BT6283) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆